Description
Overview
Enteric-coated mesalazine tablets for IBD.
Product Details
RAFASSAL 500 mg enteric-coated tablets are designed to release mesalazine in the colon to treat ulcerative colitis and Crohn’s disease. The coating protects the drug from stomach acid, ensuring delivery to the site of inflammation.
Key Benefits
- Clinically used and widely prescribed
- Supports effective symptom management
- Quality-controlled pharmaceutical product
How to Use
Use this medication exactly as prescribed by your healthcare provider. Dosage and duration depend on your condition and response to treatment.
Important Information
- Prescription may be required
- Consult your doctor before use
- Read the patient leaflet for full safety information
Reviews
There are no reviews yet.